Myasthenia Gravis clinical trials at UC Cancer
1 research study open to eligible people
Showing trials for
Descartes-08 CAR-T Cells in Generalized Myasthenia Gravis (MG)
open to eligible people ages 18 years and up
This is a Phase Ib/IIa study to evaluate the safety and preliminary efficacy of Descartes-08 CAR T-cells in patients with Generalized Myasthenia Gravis
at UC Irvine